|
KMID : 1161420210240020151
|
|
Journal of Medicinal Food
2021 Volume.24 No. 2 p.151 ~ p.160
|
|
|
Aucuparin Suppresses Bleomycin-Induced Pulmonary Fibrosis Via Anti-Inflammatory Activity
|
|
Lee Soo-Yeon
Park Soo-Yeon
Lee Gyeong-Eun
Kim Hyun-Sik
Kwon Jae-Hwan
Kim Mi-Jeong
Yoon Ho-Geun
|
|
|
Abstract
|
|
|
|
Idiopathic pulmonary fibrosis (IPF) is a lung disease that results in scarring of the lungs for an unknown reason. Although many studies have been conducted on IPF, precise mechanisms and treatments have not yet been identified. In this study, we found that aucuparin, a natural product isolated from Sorbus aucuparia, inhibited pulmonary fibrosis in a bleomycin (BLM)-induced lung fibrosis mouse model. In the lung samples of mice treated with aucuparin, the gene expression of inflammation and macrophage activation markers was reduced compared to those treated with BLM alone. Moreover, aucuparin decreased the expression of profibrotic marker genes and increased the expression of antifibrotic marker genes. Finally, we observed that aucuparin significantly suppressed transforming growth factor-β-induced activation of inflammatory cytokine production and collagen synthesis from macrophages and fibroblasts, respectively. Taken together, these data demonstrate that aucuparin inhibits lung fibrosis via its anti-inflammatory action and support its potential to be a therapeutic drug for IPF treatment.
|
|
|
KEYWORD
|
|
|
aucuparin, bleomycin, inflammation, pulmonary fibrosis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|